- Home
- ANL vs FMY Comparison
ANL vs FMY Comparison
Compare ANL & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANL
- FMY
- Stock Information
- Founded
- ANL 2004
- FMY 2005
- Country
- ANL Cayman Islands
- FMY United States
- Employees
- ANL N/A
- FMY N/A
- Industry
- ANL
- FMY Finance/Investors Services
- Sector
- ANL
- FMY Finance
- Exchange
- ANL Nasdaq
- FMY Nasdaq
- Market Cap
- ANL 56.0M
- FMY 50.5M
- IPO Year
- ANL 2023
- FMY N/A
- Fundamental
- Price
- ANL $1.45
- FMY $12.24
- Analyst Decision
- ANL Hold
- FMY
- Analyst Count
- ANL 1
- FMY 0
- Target Price
- ANL N/A
- FMY N/A
- AVG Volume (30 Days)
- ANL 6.9K
- FMY 10.1K
- Earning Date
- ANL 08-12-2025
- FMY 01-01-0001
- Dividend Yield
- ANL N/A
- FMY 6.98%
- EPS Growth
- ANL N/A
- FMY N/A
- EPS
- ANL N/A
- FMY N/A
- Revenue
- ANL N/A
- FMY N/A
- Revenue This Year
- ANL N/A
- FMY N/A
- Revenue Next Year
- ANL N/A
- FMY N/A
- P/E Ratio
- ANL N/A
- FMY N/A
- Revenue Growth
- ANL N/A
- FMY N/A
- 52 Week Low
- ANL $1.10
- FMY $10.71
- 52 Week High
- ANL $3.89
- FMY $12.17
- Technical
- Relative Strength Index (RSI)
- ANL 44.72
- FMY 54.61
- Support Level
- ANL $1.48
- FMY $12.21
- Resistance Level
- ANL $1.55
- FMY $12.30
- Average True Range (ATR)
- ANL 0.04
- FMY 0.05
- MACD
- ANL -0.00
- FMY -0.00
- Stochastic Oscillator
- ANL 25.00
- FMY 53.85
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
About FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.